Skip to content

Role of Abhayarishtadi churna and Panchnimba churna in the management of Ekakushtha(Plaque Psoriasis).

Comparative study to evaluate the efficacy of Abhayarishtadi churna and Panchnimba churna in the management of Ekakushtha(Plaque Psoriasis).

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042490
Enrollment
56
Registered
2022-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Ch Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient showing sign and symptoms of Ekakushtha as mentioned in Charak Samhita. 2) Psoriasis as diagnosed on the basis of Modern classics. 3) Patient within the age group of 20-60 years. 4) Disease duration more than 1year and less than 5years. 5) Patients not taking corticosteroids since last one month.

Exclusion criteria

Exclusion criteria: 1)Patients of Diabetes mellitus, hypertension, Thyroid disorder, tuberculosis, carcinoma, other lifeâ??threatening and complicated disease and major systemic illnesses. 2)Severe condition of Psoriasis like Psoriatic arthritis. 3)Disease duration less than 1year and more than 5years. 4)Patients on treatment with any conventional oral medicines for last one month. 5)Pregnant & lactating mother. 6)Age below 20 and above 60 years.

Design outcomes

Primary

MeasureTime frame
Improvement in Psorasis Area and Severity Index(PASI)Score. Timepoint: Day 1 Day 15 Day30 Day 45

Secondary

MeasureTime frame
1)Improvement in symptom severity of Ekakushtha(Plaque Psorasis). 2)Improvement in values of CBC,ESRTimepoint: Day 1 Day 15 Day 30 Day 45

Countries

India

Contacts

Public ContactDr Jyoti kumari

Ch.Brahm Prakash Ayurved Charak Sansthan,Khera Dabar,Najafgarh,New Delhi

yk860451@gmail.com8130735255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026